rdf:type |
|
lifeskim:mentions |
umls-concept:C0000097,
umls-concept:C0000098,
umls-concept:C0010097,
umls-concept:C0016693,
umls-concept:C0031001,
umls-concept:C0036075,
umls-concept:C0044447,
umls-concept:C0063146,
umls-concept:C0162512,
umls-concept:C0206056,
umls-concept:C0524466,
umls-concept:C1280500,
umls-concept:C1515655
|
pubmed:issue |
1-2
|
pubmed:dateCreated |
1992-12-4
|
pubmed:abstractText |
Increased formation of hydroxyl free radicals (.OH) reflected by .OH adduct of salicylate in brain dialysate was demonstrated during the sustained (more than 2 hours) dopamine overflow elicited by 75 nmol of 1-methyl-4-phenyldihydropyridine (MPDP+) and 1-methyl-4-phenylpyridinium (MPP+) in the rat striatum. Owing to its weak dopamine releasing action, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) did not significantly increase the .OH formation. This data suggests that sustained elevation of dopamine in the extracellular fluid elicited by MPTP analogues can be auto-oxidized, which in turn leads (possibly by indirect mechanisms) to the formation of cytotoxic .OH free radicals near the nigrostriatal terminals.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/1-(4-methoxyphenyl)pyridinium,
http://linkedlifedata.com/resource/pubmed/chemical/1-Methyl-4-phenyl-1,2,3,6-tetrahydro...,
http://linkedlifedata.com/resource/pubmed/chemical/1-methyl-4-phenyl-2,3-dihydropyridin...,
http://linkedlifedata.com/resource/pubmed/chemical/Free Radicals,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxides,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxyl Radical,
http://linkedlifedata.com/resource/pubmed/chemical/Pyridinium Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Salicylic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Salicylic Acids
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0300-9564
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
89
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
139-45
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:1329855-1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine,
pubmed-meshheading:1329855-Animals,
pubmed-meshheading:1329855-Corpus Striatum,
pubmed-meshheading:1329855-Dialysis,
pubmed-meshheading:1329855-Dopamine,
pubmed-meshheading:1329855-Free Radicals,
pubmed-meshheading:1329855-Hydroxides,
pubmed-meshheading:1329855-Hydroxyl Radical,
pubmed-meshheading:1329855-Male,
pubmed-meshheading:1329855-Nerve Endings,
pubmed-meshheading:1329855-Perfusion,
pubmed-meshheading:1329855-Pyridinium Compounds,
pubmed-meshheading:1329855-Rats,
pubmed-meshheading:1329855-Rats, Sprague-Dawley,
pubmed-meshheading:1329855-Salicylic Acid,
pubmed-meshheading:1329855-Salicylic Acids,
pubmed-meshheading:1329855-Substantia Nigra
|
pubmed:year |
1992
|
pubmed:articleTitle |
In vivo trapping of hydroxyl free radicals in the striatum utilizing intracranial microdialysis perfusion of salicylate: effects of MPTP, MPDP+, and MPP+.
|
pubmed:affiliation |
National Institute of Neurological Disorders and Stroke, Bethesda, Md.
|
pubmed:publicationType |
Journal Article
|